Gennova vax gets nod for ph 2/3 trials
Gennova vax gets nod for ph 2/3 trials India’s first mRNA-based Covid-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for phase 2/3 clinical trails, the department of biotechnology (DBT) said on Tuesday. https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment